Entera Bio Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Entera Bio Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011876
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that offers development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical ingredients. It conducts clinical trials of three candidate drugs based on applying Entera’s technology to teriparatide for the treatment of hypoparathyroidism, osteoporosis, and bone healing. The company also offers clinical trial programs and orphan drug designation for hypoparathyroidism. Entera Bio is headquartered in Jerusalem, Israel.

Entera Bio Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Equity Offering 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 12
Entera Bio Files Registration Statement for IPO of Shares for up to USD50 Million 13
Acquisition 14
D.N.A Biomedical Completes Acquisition Of 47% JV Stake In Entera Bio From Oramed For US$1 Million 14
Entera Bio Ltd – Key Competitors 15
Entera Bio Ltd – Key Employees 16
Entera Bio Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Mar 28, 2016: EnteraBio: New Director – Roger L. Garceau 18
Product Approvals 19
Jun 29, 2016: EnteraBio Receives Orphan Drug Approval for PTH 1-34 from European Medicines Agency 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Entera Bio Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Entera Bio Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 12
Entera Bio Files Registration Statement for IPO of Shares for up to USD50 Million 13
D.N.A Biomedical Completes Acquisition Of 47% JV Stake In Entera Bio From Oramed For US$1 Million 14
Entera Bio Ltd, Key Competitors 15
Entera Bio Ltd, Key Employees 16

★海外企業調査レポート[Entera Bio Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Misr Hotels Co:企業の戦略・SWOT・財務分析
    Misr Hotels Co - Strategy, SWOT and Corporate Finance Report Summary Misr Hotels Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Inogen Inc (INGN):企業の財務・戦略的SWOT分析
    Summary Inogen Inc (Inogen) is a medical device company that offers oxygen therapy technology solutions. The company offers products which include g2 portable oxygen concentrator system, g3 portable oxygen concentrator system, home oxygen concentrator and accessory items. Its products are used in bo …
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • Midwest Energy Cooperative:発電所・企業SWOT分析
    Midwest Energy Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Treeway BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company provides pipeline products such as TW001, an oral formulation of edaravone, which protects against neuronal apoptosis and oxidative stress. It offers prod …
  • First Bank of Nigeria Ltd:企業の戦略・SWOT・財務情報
    First Bank of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report Summary First Bank of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Xcite Energy Limited (XEL)-石油・ガス分野:企業M&A・提携分析
    Summary Xcite Energy Limited (Xcite Energy) is a heavy oil appraisal and development company. It focuses on the development of discovered oil resources in the UK North Sea. Xcite Energy has 100% working interest in the Bentley field in the UK North Sea. It also holds and operates three other blocks …
  • FactSet Research Systems Inc. (FDS):企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hydra Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulm …
  • Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析
    Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ZWACK Unicum Nyrt:戦略・SWOT・企業財務分析
    ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report Summary ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • University of Pittsburgh:企業のM&A・事業提携・投資動向
    University of Pittsburgh - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pittsburgh Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Tiger Brands Ltd (TBS):企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • STMicroelectronics N.V.:企業の戦略・SWOT・財務分析
    STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report Summary STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) is a technology company that carries out manufacturing of electron tube. The company offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equip …
  • National Oilwell Varco Inc (NOV):石油・ガス:M&Aディール及び事業提携情報
    Summary National Oilwell Varco Inc (NOV) is a provider of technology, equipment, and services to the oil and gas industry. The company’s portfolio of offerings includes rig systems, wellbore technologies, and completion and production solutions. Its product line comprises fiber glass systems, floati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆